Suchergebnisse - "Barlesi, F"

PubPharm (258)

21

Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignancies

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Pommeret, F. | Colomba, J. | Bigenwald, C. | +13

22

Radiotherapy for oligometastatic non-small cell lung cancer patients

enthalten in: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique | 2021

von Levy, A. | Roux, C. | Mercier, O. | +4

23

Severe COVID-19 in patients with hematological cancers presenting with viremia

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Michot, J. | Hueso, T. | Ibrahimi, N. | +14

24

Targeting KRAS in non-small-cell lung cancer : recent progress and new approaches

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Reck, M. | Carbone, D. | Garassino, M. | +1

25

Patient-reported outcomes from STARTRK-2 : a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

enthalten in: ESMO open | 2021

von Paz-Ares, L. | Barlesi, F. | Siena, S. | +12

26

PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Blons, H. | Oudart, J. | Merlio, J. | +18

27

Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers : a report from the ESMO Precision Medicine Working Group

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Mosele, F. | Remon, J. | Mateo, J. | +19

28

Managing cancer patients during the COVID-19 pandemic : an ESMO multidisciplinary expert consensus

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Curigliano, G. | Banerjee, S. | Cervantes, A. | +76

29

Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure : a case report

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Michot, J. | Albiges, L. | Chaput, N. | +12

30

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Mazieres, J. | Cropet, C. | Montané, L. | +20